Back
Cresco Labs Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
36
CRLBF
Cresco Labs
Last Price:
1.65
Seasonality Move:
-5.11%
Sell
50
NBY
NovaBay Pharmaceuticals
Last Price:
0.70
Seasonality Move:
-18.64%
Sell
36
Cresco Labs (CRLBF)
is a Sell
Is Cresco Labs a Buy, Sell or Hold?
- The current Cresco Labs [CRLBF] share price is $1.68. The Score for CRLBF is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- CRLBF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.73. The Score for NBY is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CRLBF Stock Price Chart
What is Cresco Labs's stock price today?
-
The Cresco Labs share price today is $1.68
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRLBF is experiencing slight selling pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.73
The current trend is relatively stagnant and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRLBF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 50.91 | Buy |
Chaikin Money Flow: | -37322 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.58 - 1.72) | Buy |
Bollinger Bands (100): | (1.55 - 1.91) | Sell |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 59.35 | Buy |
Chaikin Money Flow: | 367837 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.44 - 0.64) | Buy |
Bollinger Bands (100): | (0.46 - 3.26) | Sell |
CRLBF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.66 | Buy |
20-day SMA: | 1.65 | Buy |
50-day SMA: | 1.66 | Buy |
200-day SMA: | 1.82 | Sell |
8-day EMA: | 1.67 | Buy |
20-day EMA: | 1.67 | Buy |
50-day EMA: | 1.68 | Sell |
200-day EMA: | 1.79 | Sell |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.64 | Buy |
20-day SMA: | 0.54 | Buy |
50-day SMA: | 0.71 | Buy |
200-day SMA: | 3.55 | Sell |
8-day EMA: | 0.66 | Buy |
20-day EMA: | 0.6 | Buy |
50-day EMA: | 0.91 | Sell |
200-day EMA: | 7.97 | Sell |
Cresco Labs Earnings Growth & CRLBF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.19 per share, and an increase next year of $0.12 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $13.87 per share, an increase next quarter of $0.05 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.
Cresco Labs Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |